PRESS RELEASES

05 November 2014

2nd Preclinical Autoimmune Disease Proof of Concept for INV-17 ROR Gamma Inhibitor Portfolio Established in Rheumatoid Arthritis: Superior Therapeutic Efficacy Data to be Presented at the 2014 American College of Rheumatology Meeting

Read more +

15 January 2014

Innovimmune's Preclinical Efficacy Data on Highly Selective ROR Gamma Inhibitor of the INV-17 Program Prevents Multiple Sclerosis in Mice

 

Read more +